Clinical Trial

Amino Acid PET to Assess the Efficacy of IDH Inhibitor Treatments for IDH Mutated Gliomas

Study acronym: TEP-IDH
Completed
View on ClinicalTrials.gov →
Summary
Amino acid PET imaging could represent a biomarker for the evaluation of IDH inhibitor treatments for patients with refractory IDH-mutated gliomas
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-04.
Status change: Not Yet Recruiting → Completed 2026-06-23
Trial Details
NCT Number NCT07017790
Lead Sponsor Central Hospital, Nancy, France
Conditions Glioma
Enrollment 22 participants
Start Date 2025-06-30
Primary Completion 2025-07-01 (estimated)
Study Completion 2025-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-25